JW Pharmaceutical Corp
KRX:001060

Watchlist Manager
JW Pharmaceutical Corp Logo
JW Pharmaceutical Corp
KRX:001060
Watchlist
Price: 28 300 KRW 5.79% Market Closed
Market Cap: 674.7B KRW

Operating Margin

12.5%
Current
Improving
by 0.7%
vs 3-y average of 11.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
12.5%
=
Operating Income
₩95.8B
/
Revenue
₩764.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
12.5%
=
Operating Income
₩95.8B
/
Revenue
₩764.2B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
JW Pharmaceutical Corp
KRX:001060
647.7B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
221.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
213.9B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
No Stocks Found

Market Distribution

Higher than 82% of companies in Korea
Percentile
82st
Based on 275 companies
82st percentile
12.5%
Low
-328.3% — 1.5%
Typical Range
1.5% — 9.2%
High
9.2% — 417.9%
Distribution Statistics
Korea
Min -328.3%
30th Percentile 1.5%
Median 5.8%
70th Percentile 9.2%
Max 417.9%

JW Pharmaceutical Corp
Glance View

Market Cap
674.7B KRW
Industry
Pharmaceuticals

JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The firm mainly produces and sells drugs including supplying protein amino acids in blood, blood and fluid substitutes, hyperlipidemia agents, electrolyte additives, angina pectoris agents, rheumatoid arthritis drugs, perfusion fluid, prostatic hypertrophy drugs, hepatic coma drugs, and iron injections, among others. The firm also researches and develops anticancer drugs.

JW Pharmaceutical Corp Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
12.5%
=
Operating Income
₩95.8B
/
Revenue
₩764.2B
What is JW Pharmaceutical Corp's current Operating Margin?

The current Operating Margin for JW Pharmaceutical Corp is 12.5%, which is above its 3-year median of 11.9%.

How has Operating Margin changed over time?

Over the last 3 years, JW Pharmaceutical Corp’s Operating Margin has increased from 6.9% to 12.5%. During this period, it reached a low of 6.9% on Aug 30, 2022 and a high of 13.6% on Mar 31, 2024.

Back to Top